According to Harvard Bioscience's latest financial reports the company's current earnings are C$85.53 Million. In 2025 the company made an earning of -C$80.79 Million a decrease over its 2024 earnings that were of -C$16.43 Million. The earnings displayed on this page is the company's Pretax Income.